Clinical Commander

All dossiers
ob.amniotic-fluid-embolism.v1

Amniotic Fluid Embolism (AFE)

obstetricsacuteadultpregnancyacuteinpatient

NEW Phase C dossier — authored 2026-05-15 for shard-5-obped-id. Covers amniotic fluid embolism (AFE) — rare (1–12 per 100,000 deliveries) but catastrophic anaphylactoid syndrome of pregnancy with sudden cardiopulmonary collapse + hypoxia + DIC during labor / delivery / immediate postpartum (within 30 min). Historical maternal mortality 20–80%; modern critical care ~ 20%. Clark 2016 PMID 27372270 diagnostic criteria are the canonical anchor; AFE is a clinical diagnosis with no specific confirmatory test. Manifest field intentionally blanked (manifest: "") per shard-5 precedent on peds.febrile-infant.core.v1, id.influenza.core.v1, id.neonatal-sepsis.early-late.v1, peds.neonatal-abstinence-syndrome.v1, ob.chorioamnionitis.v1, ob.placental-abruption.v1, psych.eating-disorders.core.v1 — seed manifest authoring at prisma/seed/manifests/ob.amniotic-fluid-embolism.v1.{ts,atoms.ts} is out-of-shard scope and deferred to a future shard. Cross-engine manifest reuse (e.g., pointing to id.sepsis.core.v1 manifest) considered but rejected — semantically misleading (sepsis manifest does not describe AFE-specific atoms — Clark 2016 criteria, biphasic hemodynamic phase staging, perimortem cesarean decision, A-OK regimen, VA-ECMO trigger). _registry.ts NOT modified per refined shard-5 pattern (3-file set only: dossier TS + brief + research bundle). Registry edit deferred to a future shard. Distinct from cardio.cardiogenic-shock.amniotic-fluid-embolism.v1 (sibling — CS phenotype of AFE; this dossier is the OB-led diagnostic anchor; cardio sibling covers MCS + advanced shock management depth), id.sepsis.core.v1 (sibling — fever ≥ 38.0°C excludes AFE per Clark 2016 criterion 4; chorio + AFE-like collapse can co-present), allergy.anaphylaxis.v1 (sibling — anaphylactoid pattern overlap; allergen + skin findings + tryptase differentiate), ob.postpartum-hemorrhage.core.v1 (sibling — AFE-DIC manifests as uterine atony + multi-site bleeding; PPH uterotonic ladder + tamponade run concurrently), ob.placental-abruption.v1 (sibling — abruption-DIC differential; painful bleeding + uterine tenderness + retroplacental clot differentiate). Sibling differentiation explicitly encoded for all five. Phenotype matrix (biphasic phase × severity × delivery status × differential anchor cross-product — many cells collapsed to 9 anchor combinations) encoded indirectly via regimen_axes.amniotic_fluid_embolism_acute_resuscitation.steps (acls_with_perimortem_cesarean / vasoactive_support_for_afe_shock / pulmonary_vasodilators_for_phase_1_afe / massive_transfusion_for_dic / a_ok_empiric_combination / va_ecmo_for_refractory_afe / post_rosc_neuroprotection) + severity_triggers (9 phenotype-specific triggers) + setting playbooks (ed / inpatient / icu / outpatient). First-class TS phenotype field is schema-blocked. Severity triggers (9): afe_at_presentation_emergent_resuscitation (life_threatening — ATLS + ACLS + emergent delivery), perimortem_cesarean_within_4_5_min (life_threatening — maternal cardiac arrest in 3rd trimester), afe_with_dic_hemorrhage (life_threatening — MTP + cryoprecipitate + TXA), pulm_htn_with_rv_failure_afe_phase_1 (life_threatening — iNO + sildenafil + milrinone + epoprostenol), lv_failure_afe_phase_2 (life_threatening — inotropes + cautious fluid + ECMO consideration), afe_refractory_va_ecmo (life_threatening — multidisciplinary; mortality ~ 50% on ECMO but recovery achievable), afe_survivor_hypoxic_ischemic_injury (severe — neurology + neuropsych + TTM if comatose post-ROSC), afe_in_subsequent_pregnancy (moderate — recurrence rare ~ 1%; not contraindicated but high-risk MFM coordination), differential_from_pe_septic_anaphylaxis_eclampsia (severe — broad ddx workup in parallel with resuscitation). Bayesian linkage (per §5.5.2): pre-test priors documented in _research-bundles/ob.amniotic-fluid-embolism.v1.md — AFE incidence 1–12 per 100,000 deliveries; historical maternal mortality 20–80%, modern ~ 20%; perinatal mortality 9–44%; recurrence in subsequent pregnancy rare ~ 1% (AFE Registry data). Key LRs: clinical triad (sudden cardiopulmonary collapse + hypoxia + DIC during labor / delivery / immediate postpartum) LR+ very high for AFE when alternative explanations excluded; fever ≥ 38.0°C strongly negative LR for AFE (Clark 2016 criterion 4 exclusion); preceding painful bleeding + uterine tenderness LR+ for placental-abruption-DIC over AFE; allergen exposure + skin findings + tryptase elevation LR+ for anaphylaxis over AFE; recent immobility + prior VTE + thrombophilia LR+ for PE over AFE; pre-eclampsia history + HTN + seizure + magnesium response LR+ for eclampsia over AFE. Conditional dependencies modeled: temporal-association × delivery-window coupling (Clark 2016 criterion 3 — within 30 min); biphasic phase × treatment-emphasis coupling (phase 1 RV failure → pulmonary vasodilators; phase 2 LV failure → inotropes); maternal-arrest × GA-ge-20-to-24-wk coupling (perimortem cesarean within 4–5 min). Decision thresholds: T_treat (AFE empiric resuscitation) = sudden cardiopulmonary collapse + hypoxia + temporal association even without DIC confirmation; T_perimortem-cesarean = maternal arrest + GA ≥ 20–24 wk + no ROSC in 4–5 min; T_VA-ECMO = refractory shock on max NE + AVP + milrinone + iNO + epoprostenol + MTP; T_TTM = post-ROSC persistent coma + no rapidly reversible cause. Cross-dossier routing: cardio.cardiogenic-shock.amniotic-fluid-embolism.v1 (MCS / ECMO depth), id.sepsis.core.v1 (sepsis differential with chorio overlap), allergy.anaphylaxis.v1 (anaphylactoid differential), ob.postpartum-hemorrhage.core.v1 (concurrent DIC + hemorrhage management), ob.placental-abruption.v1 (abruption-DIC differential), pulm.pe.core.v1 (PE differential). ROS/DDx LR seed data NOT touched (cross-cutting; not in shard scope). Settings (4): ED (community-recognised sudden collapse in pregnancy → ACLS / ATLS + left-uterine displacement + immediate L&D / OR transfer + multidisciplinary team activation), Inpatient L&D (primary venue; intrapartum / immediate postpartum recognition + perimortem cesarean if maternal arrest + GA ≥ 20–24 wk + MTP + multidisciplinary critical care + transition to ICU), ICU (refractory cardiopulmonary collapse + DIC + post-arrest care + multidisciplinary critical care + ECMO consideration + TTM + family/ethics support), Outpatient (6-wk postpartum visit + AFE-specific anticipatory guidance — HIE survivor evaluation + peripartum PTSD / postpartum depression + subsequent-pregnancy counseling — recurrence rare ~ 1% but not contraindicated; tertiary center delivery recommended; family + survivor support via AFE Foundation). Drug guidance grounded in Clark 2016 PMID 27372270 + SMFM 9 Pacheco 2016 PMID 26987420 + AHA 2015 maternal arrest PMID 26443610 + AHA 2024 update + Pacheco massive transfusion in obstetrics 2016 PMID 26348379 + WOMAN 2017 PMID 28456509 + ESC Pregnancy 2018 PMID 30165544 + ESC HF 2021 + AHA 2020 post-arrest + ELSO 2020 + Sharma ECMO in pregnancy 2015 PMID 25248040 + Rezai 2017 PMID 29430313 (A-OK). RxCUIs RxNav-verified-live 2026-05-25: epinephrine (3992), amiodarone (703), norepinephrine (7512), vasopressin (11149), dobutamine (3616), milrinone (52769), sildenafil (136411), epoprostenol (8814), methylene blue (6878), atropine (1223), ondansetron (26225), ketorolac (35827), tranexamic acid (10691), midazolam (6960), fentanyl (4337), ferrous sulfate (24947), sertraline (36437). NOTE: prior seed codes for amiodarone (1191=aspirin), norepinephrine (7980=penicillin G), milrinone (6932=miconazole), sildenafil (36117=salmeterol), epoprostenol (78712=invalid), methylene blue (6918=metoprolol), tranexamic acid (10689=tramadol), ondansetron (7805=oxyfedrine), fentanyl (8163=phenylephrine), ferrous sulfate (4053=erythromycin), sertraline (32937=paroxetine) were ALL WRONG drugs and have been corrected. Influenza vaccine RxCUI (1656584) is invalid (RxNav not-found) and left UNRECOVERABLE — no clean active RxNorm drug-concept resolvable for plain influenza vaccine via property.json (vaccine concepts are CVX-coded; ingredient-class concept 5806 is not in the active status index). Open gaps: (1) Phenotype matrix not first-class TS field — schema-blocked. (2) Bayesian LR seed data not encoded — lives in narrative + research bundle only this pass; ROS/DDx seed edit cross-cutting. (3) Cross-engine manifest reuse considered for INTEGRATED promotion but rejected — semantically misleading; safer pattern is blank-manifest + PLANNED. (4) Manifest file not authored this pass — shard precedent for manifest: "" with seed deferred. (5) Co-located test file (ob.amniotic-fluid-embolism.test.ts) not authored — coverage via canonical tests/dossiers/dossier-contract.test.ts only. (6) _registry.ts NOT modified per refined shard-5 pattern — registry edit deferred to a future shard. (7) SMFM Consult Series 9 (Pacheco 2016) is cited by year + series number; underlying PMID 26987420 is the indexed reference. (8) AHA 2024 maternal arrest update extends the 2015 framework (Jeejeebhoy PMID 26443610); 2024 update specific PMID pending PubMed indexing. (9) Citation + RxCUI live-verification pass 2026-05-25: 3 fabricated PMIDs corrected (27926601→25248040 Sharma ECMO ASAIO 2015; 28386489→29430313 Rezai A-OK Case Rep Obstet Gynecol 2017; 30447216→26348379 Pacheco massive transfusion obstetrics AJOG 2016) and 11 wrong-drug RxCUIs corrected (see Drug guidance note). Influenza vaccine RxCUI (1656584) left UNRECOVERABLE — invalid but no clean active RxNorm drug-concept resolvable. amiodarone now correctly coded 703 (prior 1191 was aspirin). Status declared PLANNED with manifest: "" — audit surfaces "missing manifest pointer" as a next-tier requirement; broken_pointers should be empty since blank pointer is skipped by audit. Per shard precedent, this is acceptable for new Phase C dossiers awaiting manifest authoring in a future shard.

Entry points (6)

  • vital_abnormality
    Sudden cardiovascular collapse (SBP < 90 / MAP < 65 / cardiac arrest) + hypoxia (SpO2 < 90 / cyanosis / dyspnea) during labor, delivery, or within 30 min postpartum — gateway clinical feature (Clark 2016 PMID 27372270)
    sudden_cardiopulmonary_collapse_in_labor_or_immediate_postpartum
  • symptom
    Sudden onset severe dyspnea + altered mental status / agitation / seizure-like activity in labor or immediate postpartum — early prodrome (Clark 2016 PMID 27372270; SMFM 9 Pacheco 2016 PMID 26987420)
    sudden_dyspnea_with_altered_mental_status_in_labor
  • lab_abnormality
    Sudden onset DIC features (fibrinogen < 200, platelets < 100, prolonged PT/aPTT, oozing IV sites, surgical-site / uterine bleeding) in immediate temporal association with delivery — Clark 2016 criterion 2 (PMID 27372270)
    sudden_dic_with_obstetric_hemorrhage_at_delivery
  • vital_abnormality
    Maternal cardiac arrest in 3rd trimester (≥ 20–24 wk by fundal height) with no clear cause — perimortem cesarean within 4–5 min indication (AHA 2015 maternal arrest PMID 26443610; AHA 2024 update)
    maternal_cardiac_arrest_third_trimester
  • symptom
    Acute pulmonary edema + echo RV dilation + flattened septum (phase 1 acute pulm HTN + RV failure pattern) intrapartum or immediate postpartum (SMFM 9 Pacheco 2016 PMID 26987420)
    acute_pulmonary_edema_with_rv_failure_in_labor
  • history
    Recent uterine instrumentation, amnioinfusion, D&C, or membrane rupture with subsequent acute collapse — Clark 2016 + AFE Registry temporal-association anchor
    recent_intrauterine_instrumentation_or_amnioinfusion_with_collapse

Required inputs (23)

  • maternal_bprequired
    vital • used at RED_FLAGS
    Sudden hypotension SBP < 90 OR MAP < 65 is a Clark 2016 criterion-1 component; defines hemodynamic instability driving emergent resuscitation
  • maternal_hrrequired
    vital • used at RED_FLAGS
    Bradycardia / asystole / tachyarrhythmia drives ACLS algorithm; A-OK (atropine first) may be reasonable in bradycardic AFE pattern
  • maternal_rrrequired
    vital • used at RED_FLAGS
    Tachypnea / apnea drives airway management + mechanical ventilation; respiratory failure in AFE is profound
  • maternal_spo2required
    vital • used at RED_FLAGS
    SpO2 < 90 with cyanosis or dyspnea is a Clark 2016 criterion-1 component (hypoxia); drives FiO2 1.0 + mechanical ventilation + iNO consideration
  • maternal_temperaturerequired
    vital • used at CONTEXT
    Fever ≥ 38.0°C / 100.4°F EXCLUDES AFE per Clark 2016 criterion 4 (favors sepsis ddx); critical differential anchor
  • fetal_heart_rate_baselinerequired
    vital • used at CONTEXT
    Category III FHR / bradycardia / absent FHR drives emergent delivery decision (perimortem cesarean if maternal arrest)
  • gestational_age_weeksrequired
    demographic • used at FRAME
    GA ≥ 20–24 wk drives perimortem cesarean indication if maternal arrest; preterm < 24 wk changes neonatal viability calculus
  • event_timing_in_relation_to_labor_or_deliveryrequired
    history • used at CONTEXT
    Clark 2016 criterion 3 — onset during labor, delivery, or within 30 min postpartum; temporal association is essential to the diagnosis
  • recent_intrauterine_instrumentation
    history • used at CONTEXT
    Recent membrane rupture, amnioinfusion, D&C, or uterine instrumentation are precipitating events; informs temporal-association diagnostic anchor
  • allergy_or_anaphylaxis_history
    history • used at CONTEXT
    Helps differentiate anaphylaxis from AFE; pre-event allergen exposure favors anaphylaxis; lack of trigger + temporal association with delivery favors AFE
  • thromboembolism_risk_factors
    history • used at CONTEXT
    PE differential — recent immobility, prior VTE, thrombophilia raise PE pretest probability; CT-PA if AFE/PE ambiguity persists after initial resuscitation
  • preeclampsia_or_eclampsia_history
    history • used at CONTEXT
    Eclamptic seizure ddx — pre-eclampsia history + HTN + seizure-like activity favors eclampsia (magnesium responsive); AFE typically lacks this profile
  • maternal_cbc_with_diffrequired
    lab • used at INITIAL_WORKUP
    Platelet count for DIC surveillance (Clark 2016 criterion 2); baseline Hgb for hemorrhagic-shock trajectory
  • maternal_coagulation_panel_pt_inr_aptt_fibrinogenrequired
    lab • used at INITIAL_WORKUP
    DIC surveillance — fibrinogen < 200 mg/dL in pregnancy is profoundly low (baseline 350-650); prolonged PT/aPTT; ISTH Pregnancy DIC score; routes to cryoprecipitate + FFP + platelets
  • maternal_type_and_screen_or_crossmatchrequired
    lab • used at INITIAL_WORKUP
    Massive transfusion protocol activation; uncrossmatched O-negative if life-threatening + type-pending; crossmatched once available
  • maternal_metabolic_panelrequired
    lab • used at INITIAL_WORKUP
    Renal function trajectory (hypoperfusion-AKI), electrolytes (K+ in massive transfusion), liver function (DIC + congestion ddx with HELLP)
  • maternal_lactaterequired
    lab • used at INITIAL_WORKUP
    Shock marker; rising lactate drives MCS + ECMO consideration in refractory AFE
  • maternal_arterial_blood_gasrequired
    lab • used at INITIAL_WORKUP
    Hypoxemia + acidosis pattern; AaDO2 + PaO2/FiO2 ratio guide ventilation + ECMO threshold
  • maternal_troponin_and_bnp
    lab • used at INITIAL_WORKUP
    Rule out concurrent ACS / cardiomyopathy; elevated in AFE due to RV strain + low CO; serial trajectory marker
  • maternal_d_dimer
    lab • used at BRANCHING_WORKUP
    PE differential — markedly elevated in both AFE and PE; not diagnostic but helps rule-in thromboembolic process when CT-PA unavailable
  • bedside_transthoracic_echocardiogramrequired
    imaging • used at INITIAL_WORKUP
    Phase 1 AFE — dilated RV + flattened septum + acute pulm HTN pattern; differentiates from LV-predominant cardiomyopathy + acute coronary syndrome; tracks recovery trajectory
  • chest_xray_or_lung_us
    imaging • used at INITIAL_WORKUP
    Pulmonary edema pattern (phase 2 AFE); pneumothorax / hemothorax differential during resuscitation; lung ultrasound B-lines pattern
  • ct_pulmonary_angiogram_if_stable_and_PE_ambiguous
    imaging • used at BRANCHING_WORKUP
    PE differential — CT-PA if patient stable enough + AFE/PE ambiguity persists; NOT prerequisite for treatment; do NOT delay resuscitation for imaging

12-phase flow (12)

  1. 1FRAME
    Catastrophic obstetric emergency — anaphylactoid syndrome of pregnancy with sudden cardiopulmonary collapse + hypoxia + DIC during labor, delivery, or within 30 min postpartum. Clark 2016 case definition (PMID 27372270) requires ALL FOUR criteria: (1) sudden cardiorespiratory arrest OR hypotension with hypoxia, (2) DIC after cardiovascular event but before large-volume hemorrhage, (3) onset during labor or within 30 min postpartum, (4) no fever and no alternative explanation. Biphasic hemodynamic pattern: phase 1 acute pulm HTN + RV failure ± arrest (minutes), phase 2 LV failure + pulmonary edema + DIC + hemorrhage. Treatment is parallel resuscitation + emergent delivery + DIC management; no specific test exists — diagnosis is clinical.
    inputs: gestational_age_weeks
    advance: GA cohort tagged; phase 1 vs phase 2 hemodynamic pattern recognised if possible (often retrospective)
  2. 2ENTRY
    Recognise via sudden cardiopulmonary collapse + hypoxia ± DIC in labor or immediate postpartum (within 30 min); early prodrome includes severe dyspnea + altered mental status + agitation + seizure-like activity. Differential includes pulmonary embolism, anaphylaxis, eclampsia, septic shock (chorio overlap), hemorrhagic shock (placental abruption, uterine rupture, atony), peripartum cardiomyopathy with cardiogenic shock, acute MI / SCAD, tension pneumothorax, total spinal anesthetic. Maternal cardiac arrest pattern triggers perimortem cesarean within 4–5 min if ≥ 20–24 wk.
    inputs: event_timing_in_relation_to_labor_or_delivery
    advance: Clinical suspicion documented; ACLS / ATLS framework activated; multidisciplinary team paged (OB + anesthesia + critical care + cardiothoracic / ECMO + neonatology + hematology)
  3. 3CONTEXT
    Capture event timing (Clark 2016 criterion 3), recent intrauterine instrumentation (membrane rupture, amnioinfusion, D&C), GA, fever / no-fever (criterion 4 — fever favors sepsis), maternal allergy history (anaphylaxis ddx), thromboembolism risk factors (PE ddx), pre-eclampsia history (eclampsia ddx), current medications, prior obstetric history. Fever ≥ 38.0°C / 100.4°F EXCLUDES AFE per Clark 2016 criterion 4.
    inputs: event_timing_in_relation_to_labor_or_delivery, maternal_temperature, recent_intrauterine_instrumentation, allergy_or_anaphylaxis_history, thromboembolism_risk_factors, preeclampsia_or_eclampsia_history, maternal_hr, maternal_rr, maternal_spo2, fetal_heart_rate_baseline
    advance: Temporal-association tier set; differential anchors (fever/no-fever, recent instrumentation, allergy/eclampsia/PE history) captured
  4. 4RED_FLAGS
    Maternal cardiac arrest in 3rd trimester → ACLS + left-uterine displacement + perimortem cesarean within 4–5 min (AHA 2015 PMID 26443610; AHA 2024 update). Profound hypoxia (SpO2 < 90 + cyanosis) → immediate intubation + FiO2 1.0 + lung-protective ventilation. Sudden hypotension (SBP < 90 / MAP < 65) → vasoactive support (NE first-line, MAP target ≥ 65). DIC features → massive transfusion protocol activation + cryoprecipitate + TXA. RV failure pattern on echo → inhaled NO + milrinone + ECMO consideration if refractory.
    inputs: maternal_bp, maternal_hr, maternal_spo2, fetal_heart_rate_baseline
    actions: protocol.septic_shock
    advance: Maternal cardiac arrest pathway activated if applicable; emergent delivery decision (perimortem cesarean) executed if criteria met; vasoactive + ventilatory support escalated; massive transfusion protocol activated if DIC features
  5. 5INITIAL_WORKUP
    STAT CBC + coag panel (PT/INR, aPTT, fibrinogen) + CMP + lactate + ABG + type & screen / crossmatch ≥ 4 units PRBC + troponin + BNP. Bedside transthoracic echocardiogram (phase 1 RV failure pattern — dilated RV, flattened septum, acute pulm HTN; differentiates from LV-predominant CMP / ACS). Chest x-ray or lung US (pulmonary edema pattern, pneumothorax ddx). Do NOT delay resuscitation for imaging — bedside echo + lung US are point-of-care.
    inputs: maternal_cbc_with_diff, maternal_coagulation_panel_pt_inr_aptt_fibrinogen, maternal_type_and_screen_or_crossmatch, maternal_metabolic_panel, maternal_lactate, maternal_arterial_blood_gas, bedside_transthoracic_echocardiogram
    actions: panel.cbc, panel.coag, panel.renal
    advance: Labs drawn; type & screen + crossmatch up; echo performed; ventilatory + vasoactive baseline established
  6. 6BRANCHING_WORKUP
    CT-PA if patient stable enough + AFE / PE ambiguity persists after initial resuscitation; do NOT delay treatment for imaging in unstable patient. D-dimer (markedly elevated in both AFE + PE — not diagnostic). Repeat coag at 30–60 min if active bleeding (DIC trajectory). ROTEM / TEG if available for targeted blood-product replacement. Blood cultures + procalcitonin if sepsis ddx active. Tryptase + IgE if anaphylaxis ddx persists. Right heart catheterization if pulmonary HTN trajectory unclear (rarely possible acutely).
    inputs: maternal_d_dimer, ct_pulmonary_angiogram_if_stable_and_PE_ambiguous, maternal_troponin_and_bnp
    advance: DIC trajectory documented; PE / sepsis / anaphylaxis differentials evaluated in parallel with resuscitation
  7. 7DIFFERENTIAL
    Pulmonary embolism (CT-PA + d-dimer + echo RV strain — overlapping; DIC pattern of AFE differentiates), anaphylaxis (allergen trigger + skin findings + tryptase + epinephrine response — overlapping anaphylactoid pattern), eclampsia (HTN + seizure + pre-eclampsia history + magnesium response), septic shock (fever + chorio overlap — Clark criterion 4 excludes AFE), peripartum cardiomyopathy with CS (LV-predominant + earlier subacute presentation), acute MI / SCAD (ECG + troponin pattern; coronary angiography), tension pneumothorax (asymmetric breath sounds + tracheal shift), total spinal anesthetic (recent neuraxial procedure + bilateral motor block), uterine rupture (prior cesarean + abdominal pain + fetal station change), placental abruption with DIC (painful bleeding + uterine tenderness + retroplacental clot if visible).
    advance: Mimics excluded or co-managed; AFE clinical diagnosis confirmed by Clark 2016 criteria or treated empirically given temporal association + DIC + cardiopulmonary collapse pattern
  8. 8RISK_STRATIFICATION
    Phase 1 (acute pulm HTN + RV failure, minutes) vs phase 2 (LV failure + pulm edema + DIC + hemorrhage) staging drives treatment emphasis. Severity tiers: at-presentation requiring ATLS + ACLS, post-arrest with ROSC, refractory shock requiring VA-ECMO, survivor with hypoxic-ischemic injury. Maternal cardiac arrest + GA ≥ 20–24 wk → perimortem cesarean within 4–5 min (AHA 2015 PMID 26443610). MAP target ≥ 65 with norepinephrine first-line. ECMO consideration when refractory to NE + milrinone + iNO + MTP; multidisciplinary team decision.
    inputs: maternal_bp, maternal_hr, fetal_heart_rate_baseline, gestational_age_weeks, bedside_transthoracic_echocardiogram
    actions: calc.qsofa
    advance: Phase 1 vs phase 2 staging assigned; severity tier + MCS / ECMO decision documented
  9. 9TREATMENT
    ATLS-style resuscitation + ACLS if cardiac arrest (left-uterine displacement if undelivered). PERIMORTEM CESAREAN WITHIN 4–5 MIN if maternal arrest + GA ≥ 20–24 wk. Mechanical ventilation FiO2 1.0 → lung-protective Vt 6 mL/kg PBW + PEEP per ARDSnet. Pulmonary vasodilators for phase 1: inhaled NO 20–40 ppm, sildenafil 20–40 mg PO/NG, IV milrinone 0.25–0.75 mcg/kg/min, inhaled / IV epoprostenol. Vasoactive support: norepinephrine first-line MAP ≥ 65; add vasopressin 0.03 U/min if NE > 0.25 mcg/kg/min; dobutamine for low CO; methylene blue 1–2 mg/kg if vasoplegia. Massive transfusion 1:1:1 (Pacheco SMFM 47 2019 PMID 26348379); cryoprecipitate 10 units if fibrinogen < 200; TXA 1 g IV within 3 h (WOMAN 2017 PMID 28456509); factor VIIa or factor concentrates as rescue per hematology. A-OK (atropine 1 mg IV + ondansetron 8 mg IV + ketorolac 30 mg IV) low-evidence empiric (Rezai 2017 PMID 29430313). VA-ECMO for refractory cardiopulmonary collapse (ELSO 2020; Sharma 2017 PMID 25248040). Targeted temperature management 32–36°C × 24 h if comatose post-ROSC.
    inputs: gestational_age_weeks, maternal_bp, maternal_spo2
    advance: Resuscitation framework executed; perimortem cesarean decision made if arrest; pulmonary vasodilator / vasoactive / MTP / ECMO decisions made per severity tier
  10. 10DISPOSITION
    OR + ICU for perimortem cesarean + post-resuscitation care. ICU level-1 trauma / cardiothoracic capability for refractory shock + ECMO. Multidisciplinary team: critical care + OB + anesthesia + cardiothoracic / ECMO + neonatology + hematology. Postpartum mother-baby unit deferred until maternal stability (typically multi-day ICU course). Neonatology / NICU coordination for emergent delivery + hypoxic-ischemic injury risk in newborn.
    inputs: maternal_bp, maternal_spo2
    advance: ICU level of care set; multidisciplinary team coordinated; neonatology pathway initiated; family + ethics conversation initiated if poor prognosis
  11. 11MONITORING
    Continuous MAP + ECG + SpO2 + capnography + arterial line + central venous catheter once on vasopressors. ABG q1–4 h during instability. Lactate q2–4 h until normalised. Serial coag panel q1–2 h while active bleeding then q4–6 h stabilising; fibrinogen target ≥ 200 with cryoprecipitate replacement; platelet target > 50K intrapartum > 100K with active hemorrhage. Echocardiography q12–24 h to track RV recovery + ECMO weaning readiness. Daily SOFA + cultures. Fetal monitoring continuous if not yet delivered. CAM-ICU once sedation lightened. Targeted temperature management 32–36°C × 24 h if comatose post-ROSC.
    inputs: maternal_bp, maternal_hr, maternal_spo2, maternal_coagulation_panel_pt_inr_aptt_fibrinogen, maternal_lactate
    actions: panel.cbc, panel.coag
    advance: Maternal stable off vasopressors; lactate < 2; coag stabilised; RV recovery on echo; extubated; CAM-ICU negative
  12. 12FOLLOWUP
    6-wk postpartum visit + AFE-specific anticipatory guidance. Survivors at risk for hypoxic-ischemic encephalopathy → neurology + neuropsychology evaluation; rehabilitation services as needed. Mental health screen — high risk for peripartum PTSD (PCL-5) + postpartum depression (EPDS) given catastrophic peripartum event. Subsequent-pregnancy counseling: recurrence rare (~ 1%; AFE Registry data); NOT a contraindication to pregnancy but high-risk MFM coordination + delivery at tertiary center with on-call critical care + ECMO capability. Newborn outpatient peds 24–48 h post-discharge + developmental tracking for first year (high CP / BPD risk if hypoxic-ischemic exposure). Cardiothoracic / pulmonology follow-up if RV recovery incomplete. Hematology follow-up if persistent coagulopathy. Family + psychosocial support; survivor support groups (AFE Foundation).
    advance: Postpartum visit complete; neurology / neuropsych / rehab assessment if HIE; mental health support engaged; subsequent-pregnancy counseling delivered; newborn developmental tracking initiated; family support arranged